CVS Health Valuation
| CVS Stock | MXN 1,151 8.74 0.75% |
At this time, the firm appears to be overvalued. CVS Health shows a prevailing Real Value of 1028.73 per share. The current price of the firm is 1151.26. Our model approximates the value of CVS Health from analyzing the firm fundamentals such as profit margin of 0.01 %, and Return On Equity of 0.0568 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CVS Health's price fluctuation is very steady at this time. Calculation of the real value of CVS Health is based on 3 months time horizon. Increasing CVS Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CVS Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CVS Stock. However, CVS Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1151.26 | Real 1028.73 | Hype 1151.26 | Naive 1166.9 |
The intrinsic value of CVS Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CVS Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CVS Health helps investors to forecast how CVS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CVS Health more accurately as focusing exclusively on CVS Health's fundamentals will not take into account other important factors: CVS Health Total Value Analysis
CVS Health is currently projected to have takeover price of 3.58 T with market capitalization of 2.13 T, debt of 50.48 B, and cash on hands of 8.32 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CVS Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.58 T | 2.13 T | 50.48 B | 8.32 B |
CVS Health Investor Information
About 83.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.83. Some equities with similar Price to Book (P/B) outperform the market in the long run. CVS Health has Price/Earnings To Growth (PEG) ratio of 1.33. The entity recorded earning per share (EPS) of 58.33. The firm last dividend was issued on the 19th of January 2023. CVS Health is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.CVS Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CVS Health has an asset utilization ratio of 141.26 percent. This suggests that the Company is making 1.41 for each dollar of assets. An increasing asset utilization means that CVS Health is more efficient with each dollar of assets it utilizes for everyday operations.CVS Health Ownership Allocation
CVS Health holds a total of 1.28 Billion outstanding shares. The majority of CVS Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CVS Health to benefit from reduced commissions. Therefore, institutional investors are subject to a different set of regulations than regular investors in CVS Health. Please pay attention to any change in the institutional holdings of CVS Health as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CVS Health Profitability Analysis
The company reported the revenue of 322.47 B. Net Income was 4.15 B with profit before overhead, payroll, taxes, and interest of 53.46 B.About CVS Health Valuation
Our relative valuation model uses a comparative analysis of CVS Health. We calculate exposure to CVS Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CVS Health's related companies.CVS Health Corporation provides health services and plans in the United States. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island. CVS HEALTH operates under Health Care Plans classification in Mexico and is traded on Mexico Stock Exchange. It employs 295000 people.
8 Steps to conduct CVS Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CVS Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CVS Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CVS Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CVS Health's revenue streams: Identify CVS Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CVS Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CVS Health's growth potential: Evaluate CVS Health's management, business model, and growth potential.
- Determine CVS Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CVS Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.